• Explore /
  • Poster
  • / STOPTRAFFIC-1: A phase I/II trial of SX-682 in combination with nivolumab for refractory <em>RAS-</em>mutated microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

STOPTRAFFIC-1: A phase I/II trial of SX-682 in combination with nivolumab for refractory RAS-mutated microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

Benny Johnson

Benny Johnson

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Benny Johnson , Scott Kopetz , Hyunsoo Hwang , Ying Yuan , Ronald Anthony DePinho , John Zebala , Michael J. Overman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT04599140

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS3638)

DOI

10.1200/JCO.2022.40.16_suppl.TPS3638

Abstract #

TPS3638

Poster Bd #

427a

Abstract Disclosures

Similar Posters

First Author: Manish R. Patel

First Author: Sarah B. Goldberg

First Author: Sheng Li

First Author: Glenn J. Hanna